FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

TR Hylan

Research Profile

Disorders

Depressive Disorder

Chemicals & Drugs

Concepts & Ideas

Procedures

Insurance Claim Review

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Eric T Edgell; TR Hylan; Jolaine Reierson Draugalis; Stephen Joel Coons
Initial treatment choice in depression: impact on medical expenditures.
C A Neslusan; TR Hylan; Rodney L Dunn; J Donoghue
Controlling for systematic selection in retrospective analyses: an application to fluoxetine and sertraline prescribing in the United Kingdom.
Eric T Edgell; K H Summers; TR Hylan; J Ober; Lyle J Bootman
A framework for drug utilization evaluation in depression: insights from outcomes research.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of TR Hylan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Eric T Edgell; TR Hylan; Jolaine Reierson Draugalis; Stephen Joel Coons
Initial treatment choice in depression: impact on medical expenditures.
PharmacoEconomics 2000;17(4):371-82.
1999: C A Neslusan; TR Hylan; Rodney L Dunn; J Donoghue
Controlling for systematic selection in retrospective analyses: an application to fluoxetine and sertraline prescribing in the United Kingdom.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 1999;2(6):435-45.
1999: Eric T Edgell; K H Summers; TR Hylan; J Ober; Lyle J Bootman
A framework for drug utilization evaluation in depression: insights from outcomes research.
Medical care 1999;37(4 Suppl Lilly):AS67-76.
1999: TR Hylan; William H Crown; LM Meneades; JH Heiligenstein; CA Melfi; Thomas W Croghan; DP Buesching
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
Medical care 1999;37(4 Suppl Lilly):AS36-44.
1999: R L Dunn; J M Donoghue; Ronald J Ozminkowski; D Stephenson; TR Hylan
Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines.
Journal of psychopharmacology (Oxford, England) 1999;13(2):136-43.
1999: TR Hylan; LM Meneades; William H Crown; J A Sacristan; Inmaculada Gilaberte; Angel L Montejo
SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study.
Journal of affective disorders 1999;52(1-3):111-9.
1999: José Antonio Sacristán; Inmaculada Gilaberte; TR Hylan; William H Crown; G Bueno; M A Garzón; Angel L Montejo
[The costs of treatment with the new antidepressants in clinical practice].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 1999;23(1):15-6, 18, 20-5.
1998: TR Hylan; Rodney L Dunn; R G Tepner; F Meurgey
Gaps in antidepressant prescribing in primary care in the United Kingdom.
International clinical psychopharmacology 1998;13(6):235-43.
1998: José Antonio Sacristán; J Soto; I Galende; TR Hylan
Randomized database studies: a new method to assess drugs' effectiveness?
Journal of clinical epidemiology 1998;51(9):713-5.
1998: Ronald J Ozminkowski; TR Hylan; CA Melfi; LM Meneades; William H Crown; Thomas W Croghan; Rebecca L Robinson
Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system.
Clinical therapeutics 1998;20(4):780-96.
1998: William H Crown; TR Hylan; LM Meneades
Antidepressant selection and use and healthcare expenditures. An empirical approach.
PharmacoEconomics 1998;13(4):435-48.
1998: Angel L Montejo; Inmaculada Gilaberte; C Fombellida; TR Hylan; José Antonio Sacristán
[Pattern of usage of new antidepressants in clinical practice].
Actas luso-españolas de neurología, psiquiatría y ciencias afines 1998;26(2):75-81.
1998: TR Hylan; DP Buesching; Gary D Tollefson
Health economic evaluations of antidepressants: a review.
Depression and anxiety 1998;7(2):53-64.
1998: TR Hylan; William H Crown; LM Meneades; JH Heiligenstein; CA Melfi; Thomas W Croghan; DP Buesching
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
Journal of affective disorders 1998;47(1-3):71-9.
1997: José Antonio Sacristán; J Soto; I Galende; TR Hylan
A review of methodologies for assessing drug effectiveness and a new proposal: randomized database studies.
Clinical therapeutics 1997;19(6):1510-7; discussion 1424-5.
1997: Eric T Edgell; TR Hylan; José Antonio Sacristán
Sertraline. A pharmacoeconomic evaluation of its use in depression.
PharmacoEconomics 1997;11(4):377-80.